摘要
目的:观察常规药物加心区交感神经阻滞(CSNB)术治疗肥厚型心肌病(HCM)的近期及远期临床疗效。方法:对7例肥厚型心肌病患者行常规药物加CSNB术治疗,比较治疗前后临床症状、NYHA心功能分级、血浆氨基末端脑钠肽前体(NT-pro BNP)水平及6 min步行试验距离变化情况,随访6个月内患者再住院率和明尼苏达生活质量评分情况。结果:治疗后患者临床症状明显改善,NYHA心功能分级明显提高,总有效率100%,6 min步行试验距离明显增加(P<0.05),血浆NT-pro BNP水平下降。随访6个月,明尼苏达生活质量评分明显下降(P<0.05),再入院率为0。结论:常规药物加心区交感神经阻滞术治疗肥厚型心肌病的近期及远期临床效果好,为肥厚型心肌病治疗提供了新方法。
Objective： To observe the short-term and long-term effect of conventional drugs plus cardiac sympathetic nerve block （ CSNB ） in treatment of patients with hypertrophic cardiomyopathy （ HCM ） .Methods：Seven patients with HCM were treated with conventional drugs plus CSNB .NYHA heart function classification , plasma NT-proBNP level and the distance change of 6 min walking test were compared before and after treatment . Readmission rate and Minnesota quality of life scale of the patients were followed up 6 months.Results： The clinical symptoms of the patients were significantly improved after treatment .At the time of hospital discharge , the NYHA was obviously improved ,the total effective rate was 100%, and the 6 min walk test distance increased （ P ＆lt;0.05） and the plasma NT-proBNP was decreased .After 6 months of follow-up, Minnesota quality of life scale＆amp;nbsp;scores decreased significantly （ P〈0.05）, the readmission rate was 0.Conclusion： The short and long-term clinical efficacy of conventional drugs plus CSNB in treatment of HCM is good , which provides a new method for treating HCM.
出处
《东南大学学报（医学版）》
CAS
北大核心
2016年第2期205-207,共3页
Journal of Southeast University(Medical Science Edition)
基金
黑龙江省科技厅基金(GC06C41902)
关键词
肥厚型心肌病
心区交感神经阻滞
临床疗效
hypertrophic cardiomyopathy
cardiac sympathetic nerve block
clinical efficacy
